Back to Results

Thermo Fisher Scientific Inc (TMO)

Thermo Fisher Scientific Inc. is a healthcare company listed on the New York Stock Exchange under the ticker TMO. The company develops and supplies life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services. Its operations are organized into four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services.

Through these businesses, Thermo Fisher serves customers involved in biological and medical research, drug and vaccine development, clinical diagnostics, and a range of pharmaceutical, biotechnology, academic, government, environmental, and industrial applications. The company also provides products and services for clinical laboratories, transplant diagnostics, microbiology, and healthcare market channels. Thermo Fisher Scientific was founded in 1956 and is headquartered in Waltham, Massachusetts.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-TMO
$537.10
3.8% Upside
Fair
$591.27
14.2% Upside
Fair
Good
September 15, 2026
October 15, 2026
1.88
0.4%
July 23, 2026
28.0x
3.7x
4.2x
195.6 B
231.6 B
18.1%
99.7%
6.2
9.5%
98.5%
Valuation • Fair Value

Thermo Fisher Scientific Inc (NYSE-TMO) Fair Value by Valuation Model

Compare the primary fair value estimate for Thermo Fisher Scientific Inc (NYSE-TMO) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$537.10

Estimated upside of 3.8% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$514.95

Discounted cash flow valuation reference.

Ben Graham Formula Value

$204.46

Classic Ben Graham valuation formula reference.

DDM Fair Value

$505.18

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$569.89

Comparable-company valuation reference.

Analyst Price Target

$591.27

Analysts imply upside of 14.2%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Thermo Fisher Scientific Inc (NYSE-TMO) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Thermo Fisher Scientific Inc (NYSE-TMO)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

45.197 B

Current operating scale indicator.

Revenue Forecast

47.739 B

Forward revenue estimate.

EBITDA

11.296 B

Current operating profitability reference.

EBITDA Forecast

12.368 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Thermo Fisher Scientific Inc (NYSE-TMO) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Thermo Fisher Scientific Inc (NYSE-TMO)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.41

No elevated caution signal from this screen.

Altman Z-Score

6.2

Relatively strong balance-sheet zone.

FCF / Net Income

98.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Thermo Fisher Scientific Inc (NYSE-TMO). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Thermo Fisher Scientific Inc (NYSE-TMO)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 23, 2026

Days to Earnings

2

Dividend Payment Date

October 15, 2026

Ex-Dividend Date

September 15, 2026

Dividend Yield

0.4%

Income yield reference.

Upcoming Dividend

1.88

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

9.5%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Thermo Fisher Scientific Inc (NYSE-TMO), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Thermo Fisher Scientific Inc (NYSE-TMO) Stock Forecast & Technical Outlook

Review Thermo Fisher Scientific Inc (NYSE-TMO) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Thermo Fisher Scientific Inc (NYSE-TMO) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Thermo Fisher Scientific Inc (NYSE-TMO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Thermo Fisher Scientific Inc (NYSE-TMO) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Thermo Fisher Scientific Inc (NYSE-TMO) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Thermo Fisher Scientific Inc (NYSE-TMO) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Thermo Fisher Scientific Inc (NYSE-TMO)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Thermo Fisher Scientific Inc (NYSE-TMO) has a Strong Buy consensus, with 18 buy, 7 hold and 0 sell recommendations in the current data set.

Buy 18
Hold 7
Sell 0
FAQ • Fast Investor Answers

Thermo Fisher Scientific Inc (NYSE-TMO) Stock FAQ

Quick answers about Thermo Fisher Scientific Inc (NYSE-TMO) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$537.10
Estimated upside 3.8%
Valuation Rating
Undervalued
Estimated upside of 3.8%
Analyst Target
$591.27
Implied upside 14.2%
Financial Health
Good
Current financial-health read

The current fair value estimate for Thermo Fisher Scientific Inc (NYSE-TMO) is $537.10. This implies an estimated upside of 3.8% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 3.8% versus the current market price.

The available analyst price target for Thermo Fisher Scientific Inc (NYSE-TMO) is $591.27. The analyst target implies estimated upside of 14.2%.

The current financial health read for Thermo Fisher Scientific Inc (NYSE-TMO) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Thermo Fisher Scientific Inc (NYSE-TMO) is July 23, 2026.

Based on the current data, dividend yield is 0.4%, upcoming dividend amount is 1.88, ex-dividend date is September 15, 2026, payment date is October 15, 2026.

The current P/E ratio listed for Thermo Fisher Scientific Inc (NYSE-TMO) is 28.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Thermo Fisher Scientific Inc is 195.6 B.

The current enterprise value listed for Thermo Fisher Scientific Inc is 231.6 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Thermo Fisher Scientific Inc is NYSE-TMO, and the stock is listed on NYSE.

Thermo Fisher Scientific Inc (NYSE-TMO) is listed on NYSE.

The current debt-to-total-capital ratio listed for Thermo Fisher Scientific Inc is 18.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Thermo Fisher Scientific Inc is 99.7%. Free float helps investors understand how much of the share base is available for public trading.

Similar Life Sciences Tools & Services Stocks on NYSE View more

Danaher Corporation (DHR) Danaher Corporation (DHR)
Agilent Technologies Inc (A) Agilent Technologies Inc (A)
Waters Corporation (WAT) Waters Corporation (WAT)
IQVIA Holdings Inc (IQV) IQVIA Holdings Inc (IQV)
Mettler-Toledo International Inc (MTD) Mettler-Toledo International Inc (MTD)
West Pharmaceutical Services Inc (WST) West Pharmaceutical Services Inc (WST)
Revvity Inc (RVTY) Revvity Inc (RVTY)
Charles River Laboratories (CRL) Charles River Laboratories (CRL)
Qiagen NV (QGEN) Qiagen NV (QGEN)
Bio-Rad Laboratories B (BIOb) Bio-Rad Laboratories B (BIOb)
Bio-Rad Laboratories Inc (BIO) Bio-Rad Laboratories Inc (BIO)
Avantor Inc (AVTR) Avantor Inc (AVTR)
Stevanato Group SpA (STVN) Stevanato Group SpA (STVN)
Ginkgo Bioworks Holdings (DNA) Ginkgo Bioworks Holdings (DNA)